BioMarin Pharmaceutical Reports Strong Quarterly Earnings
Revenue of $712.03 Million for the Quarter Ended June 2024
Conference Call and Webcast Scheduled Today at 4:30 p.m. ET
BioMarin Pharmaceutical Inc. (BMRN) reported solid financial results for the second quarter of 2024, with revenue totaling $712.03 million.
The company announced that it will hold a conference call and webcast later today at 4:30 p.m. ET to discuss the results in more detail.
Investors can access real-time stock quotes, historical data, and other important information about BMRN on financial news websites and online platforms.
تعليقات